Mortality in systemic sclerosis-a single centre study from the UK

Gemma Strickland, John Pauling, Charlotte Cavill, Gavin Shaddick, Neil McHugh

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

This study aims to determine the cause and predictors of mortality in a cohort of patients with systemic sclerosis (SSc) and assess whether the mortality rate differs significantly from the general population. Patients enrolled onto the Royal National Hospital for Rheumatic Diseases Connective Tissue Disease database between 1999 and 2010 were included in this study. The NHS Strategic Tracing Service and UK Registry of Births, Marriages and Deaths were used to establish date and cause of deaths. A retrospective case note review collected information on clinical phenotype and serology. A standardised mortality ratio (SMR) was calculated and survival was determined using Kaplan-Meier estimates. Univariate and multivariate predictors of survival were assessed using proportional hazards regression modelling. Amongst this cohort of 204 patients (25 males, 40 diffuse SSc), the mean age at diagnosis was 51.6 years (SD13.7) and the mean duration of follow-up was 12.5 years (SD 8.8 years). In the deceased group (53 patients), the mean age of death was 72.0 years (SD 12.3 years). The mean disease duration at death was 14.2 years (SD 8.5 years). The overall SMR was 1.34 (95 % confidence interval (CI) 1.00-1.75). The SMR was higher in males (1.54 [95 % CI 0.67-3.04] vs. 1.30 [95 % CI 0.95-1.74]). The leading causes of death in this cohort were infection, respiratory disease and malignancy. The most common cause of SSc-related mortality was pulmonary complications. Factors adversely affecting survival were older age at diagnosis, male gender, interstitial lung disease (ILD) and anti-RNA polymerase III antibody. The mortality rate of our cohort, who had predominantly limited disease, was higher than that of the general population; although not as high as reported in previous retrospective studies.
Original languageEnglish
Pages (from-to)1533-1539
Number of pages7
JournalClinical Rheumatology
Volume32
Issue number10
DOIs
Publication statusPublished - Oct 2013

Fingerprint

Systemic Scleroderma
Mortality
Confidence Intervals
Survival
Cause of Death
RNA Polymerase III
Diffuse Scleroderma
Connective Tissue Diseases
Interstitial Lung Diseases
Kaplan-Meier Estimate
Serology
Rheumatic Diseases
Marriage
Respiratory Tract Infections
Population
Registries
Retrospective Studies
Parturition
Databases
Phenotype

Keywords

  • Adult
  • Age Factors
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Phenotype
  • Registries
  • Regression Analysis
  • Retrospective Studies
  • Scleroderma, Systemic
  • Sex Factors
  • Time Factors
  • Treatment Outcome
  • United Kingdom
  • Journal Article
  • Research Support, Non-U.S. Gov't

Cite this

Mortality in systemic sclerosis-a single centre study from the UK. / Strickland, Gemma; Pauling, John; Cavill, Charlotte; Shaddick, Gavin; McHugh, Neil.

In: Clinical Rheumatology, Vol. 32, No. 10, 10.2013, p. 1533-1539.

Research output: Contribution to journalArticle

@article{1dfbe420da5441c19c46332c6f320d60,
title = "Mortality in systemic sclerosis-a single centre study from the UK",
abstract = "This study aims to determine the cause and predictors of mortality in a cohort of patients with systemic sclerosis (SSc) and assess whether the mortality rate differs significantly from the general population. Patients enrolled onto the Royal National Hospital for Rheumatic Diseases Connective Tissue Disease database between 1999 and 2010 were included in this study. The NHS Strategic Tracing Service and UK Registry of Births, Marriages and Deaths were used to establish date and cause of deaths. A retrospective case note review collected information on clinical phenotype and serology. A standardised mortality ratio (SMR) was calculated and survival was determined using Kaplan-Meier estimates. Univariate and multivariate predictors of survival were assessed using proportional hazards regression modelling. Amongst this cohort of 204 patients (25 males, 40 diffuse SSc), the mean age at diagnosis was 51.6 years (SD13.7) and the mean duration of follow-up was 12.5 years (SD 8.8 years). In the deceased group (53 patients), the mean age of death was 72.0 years (SD 12.3 years). The mean disease duration at death was 14.2 years (SD 8.5 years). The overall SMR was 1.34 (95 {\%} confidence interval (CI) 1.00-1.75). The SMR was higher in males (1.54 [95 {\%} CI 0.67-3.04] vs. 1.30 [95 {\%} CI 0.95-1.74]). The leading causes of death in this cohort were infection, respiratory disease and malignancy. The most common cause of SSc-related mortality was pulmonary complications. Factors adversely affecting survival were older age at diagnosis, male gender, interstitial lung disease (ILD) and anti-RNA polymerase III antibody. The mortality rate of our cohort, who had predominantly limited disease, was higher than that of the general population; although not as high as reported in previous retrospective studies.",
keywords = "Adult, Age Factors, Female, Humans, Male, Middle Aged, Multivariate Analysis, Phenotype, Registries, Regression Analysis, Retrospective Studies, Scleroderma, Systemic, Sex Factors, Time Factors, Treatment Outcome, United Kingdom, Journal Article, Research Support, Non-U.S. Gov't",
author = "Gemma Strickland and John Pauling and Charlotte Cavill and Gavin Shaddick and Neil McHugh",
year = "2013",
month = "10",
doi = "10.1007/s10067-013-2289-0",
language = "English",
volume = "32",
pages = "1533--1539",
journal = "Clinical Rheumatology",
issn = "1434-9949",
publisher = "Springer London",
number = "10",

}

TY - JOUR

T1 - Mortality in systemic sclerosis-a single centre study from the UK

AU - Strickland, Gemma

AU - Pauling, John

AU - Cavill, Charlotte

AU - Shaddick, Gavin

AU - McHugh, Neil

PY - 2013/10

Y1 - 2013/10

N2 - This study aims to determine the cause and predictors of mortality in a cohort of patients with systemic sclerosis (SSc) and assess whether the mortality rate differs significantly from the general population. Patients enrolled onto the Royal National Hospital for Rheumatic Diseases Connective Tissue Disease database between 1999 and 2010 were included in this study. The NHS Strategic Tracing Service and UK Registry of Births, Marriages and Deaths were used to establish date and cause of deaths. A retrospective case note review collected information on clinical phenotype and serology. A standardised mortality ratio (SMR) was calculated and survival was determined using Kaplan-Meier estimates. Univariate and multivariate predictors of survival were assessed using proportional hazards regression modelling. Amongst this cohort of 204 patients (25 males, 40 diffuse SSc), the mean age at diagnosis was 51.6 years (SD13.7) and the mean duration of follow-up was 12.5 years (SD 8.8 years). In the deceased group (53 patients), the mean age of death was 72.0 years (SD 12.3 years). The mean disease duration at death was 14.2 years (SD 8.5 years). The overall SMR was 1.34 (95 % confidence interval (CI) 1.00-1.75). The SMR was higher in males (1.54 [95 % CI 0.67-3.04] vs. 1.30 [95 % CI 0.95-1.74]). The leading causes of death in this cohort were infection, respiratory disease and malignancy. The most common cause of SSc-related mortality was pulmonary complications. Factors adversely affecting survival were older age at diagnosis, male gender, interstitial lung disease (ILD) and anti-RNA polymerase III antibody. The mortality rate of our cohort, who had predominantly limited disease, was higher than that of the general population; although not as high as reported in previous retrospective studies.

AB - This study aims to determine the cause and predictors of mortality in a cohort of patients with systemic sclerosis (SSc) and assess whether the mortality rate differs significantly from the general population. Patients enrolled onto the Royal National Hospital for Rheumatic Diseases Connective Tissue Disease database between 1999 and 2010 were included in this study. The NHS Strategic Tracing Service and UK Registry of Births, Marriages and Deaths were used to establish date and cause of deaths. A retrospective case note review collected information on clinical phenotype and serology. A standardised mortality ratio (SMR) was calculated and survival was determined using Kaplan-Meier estimates. Univariate and multivariate predictors of survival were assessed using proportional hazards regression modelling. Amongst this cohort of 204 patients (25 males, 40 diffuse SSc), the mean age at diagnosis was 51.6 years (SD13.7) and the mean duration of follow-up was 12.5 years (SD 8.8 years). In the deceased group (53 patients), the mean age of death was 72.0 years (SD 12.3 years). The mean disease duration at death was 14.2 years (SD 8.5 years). The overall SMR was 1.34 (95 % confidence interval (CI) 1.00-1.75). The SMR was higher in males (1.54 [95 % CI 0.67-3.04] vs. 1.30 [95 % CI 0.95-1.74]). The leading causes of death in this cohort were infection, respiratory disease and malignancy. The most common cause of SSc-related mortality was pulmonary complications. Factors adversely affecting survival were older age at diagnosis, male gender, interstitial lung disease (ILD) and anti-RNA polymerase III antibody. The mortality rate of our cohort, who had predominantly limited disease, was higher than that of the general population; although not as high as reported in previous retrospective studies.

KW - Adult

KW - Age Factors

KW - Female

KW - Humans

KW - Male

KW - Middle Aged

KW - Multivariate Analysis

KW - Phenotype

KW - Registries

KW - Regression Analysis

KW - Retrospective Studies

KW - Scleroderma, Systemic

KW - Sex Factors

KW - Time Factors

KW - Treatment Outcome

KW - United Kingdom

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

UR - http://www.scopus.com/inward/record.url?scp=84885309893&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1007/s10067-013-2289-0

U2 - 10.1007/s10067-013-2289-0

DO - 10.1007/s10067-013-2289-0

M3 - Article

C2 - 23812618

AN - SCOPUS:84885309893

VL - 32

SP - 1533

EP - 1539

JO - Clinical Rheumatology

JF - Clinical Rheumatology

SN - 1434-9949

IS - 10

ER -